VRCA
Price
$4.09
Change
-$0.02 (-0.49%)
Updated
Oct 15, 04:59 PM (EDT)
Capitalization
38.73M
26 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

VRCA

Header iconVRCA Comparison
Open Charts VRCABanner chart's image
Verrica Pharmaceuticals
Price$4.09
Change-$0.02 (-0.49%)
Volume$2.37K
Capitalization38.73M
VRCA Comparison Chart in %
VRCA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Moderna (NASDAQ:MRNA), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Sarepta Therapeutics (NASDAQ:SRPT), Novavax (NASDAQ:NVAX), Nektar Therapeutics (NASDAQ:NKTR), Inovio Pharmaceuticals (NASDAQ:INO).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.02B. The market cap for tickers in the group ranges from 58 to 104.58B. VRTX holds the highest valuation in this group at 104.58B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 1%. For the same Industry, the average monthly price growth was 18%, and the average quarterly price growth was 83%. GNPX experienced the highest price growth at 243%, while CARM experienced the biggest fall at -87%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -36%. For the same stocks of the Industry, the average monthly volume growth was 5% and the average quarterly volume growth was 112%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 81
Price Growth Rating: 51
SMR Rating: 93
Profit Risk Rating: 94
Seasonality Score: 3 (-100 ... +100)
Interact to see
Advertisement
COMPARISON
Comparison
Oct 16, 2025
Stock price -- (VRCA: $4.10)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

VRCA’s FA Score shows that 0 FA rating(s) are green while.

  • VRCA’s FA Score: 0 green, 5 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VRCA’s TA Score shows that 5 TA indicator(s) are bullish.

  • VRCA’s TA Score: 5 bullish, 4 bearish.

Price Growth

VRCA (@Biotechnology) experienced а -7.24% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +18.20%, and the average quarterly price growth was +82.76%.

Reported Earning Dates

VRCA is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRCA
Capitalization38.7M
EBITDA-38.54M
Gain YTD-41.429
P/E RatioN/A
Revenue14.7M
Total Cash15.4M
Total Debt38.9M
FUNDAMENTALS RATINGS
VRCA: Fundamental Ratings
VRCA
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
VRCA
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
VRCA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KLTO0.660.04
+6.64%
Klotho Neurosciences Inc
ARW117.481.63
+1.41%
Arrow Electronics
BV13.350.17
+1.29%
BrightView Holdings
IMMP2.100.01
+0.48%
Immutep Limited
BX163.91-0.07
-0.04%
Blackstone

VRCA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VRCA has been loosely correlated with ACOG. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if VRCA jumps, then ACOG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRCA
1D Price
Change %
VRCA100%
-0.24%
ACOG - VRCA
33%
Loosely correlated
+3.58%
PBYI - VRCA
30%
Poorly correlated
+3.48%
SLNO - VRCA
29%
Poorly correlated
+6.48%
FGEN - VRCA
29%
Poorly correlated
-0.27%
QURE - VRCA
27%
Poorly correlated
+6.63%
More